期刊文献+

海生素注射液抗肿瘤作用的实验研究 被引量:11

An experiment study on antitumor effect of Haishengsu injection
在线阅读 下载PDF
导出
摘要 目的 :研究海生素的抗肿瘤效果。方法 :采用小鼠移植性实体瘤S180 、艾氏腹水瘤 (EAC)和肝癌实体瘤 (Heps)模型的抑瘤试验 ,尾静脉给予小鼠不同剂量的海生素 ,计算抑瘤率和荷瘤小鼠生命延长率。结果 :海生素在 4 90~ 10 0 0mg·kg- 1·d- 1剂量范围内对小鼠S180 和Heps的抑瘤率分别达到 4 1.10 %~ 4 9.0 8%和 36 .2 9%~ 4 9.19% ,对EAC小鼠的生命延长率为 2 2 .93%~ 6 9.98%。结论 :海生素对荷瘤小鼠具有明显的抑瘤作用 ,在有效治疗肿瘤的同时对小鼠体重无明显影响。 Objective To investigate the antitumor effect of Haishengsu injection extracted from marine shellfish. Methods Transplant tumor models of sarcoma 180 (S 180), Ehrlich ascites carcinoma (EAC), and hepatoma (Heps) in mice were established. Different doses of Haishengsu injection were given to the mice and the tumor inhibition rates of Haishengsu injection, life span of the mice were calculated. Results The tumor inhibition rates of haishengsu injection (490~1000mg·kg -1·d -1,iv) were 41.10%~49.08% in mice with S 180 and 36.29%~49.19% in mice with hepatoma,respectively. The same doses of Haishengsu injection prolonged the life spans of EAC-bearing mice by 22.93%~69.98%. Conclusion The haishengsu injection has the antitumor effects on the tumor-bearing mice without evident side effects.
出处 《中国海洋药物》 CAS CSCD 2004年第5期35-37,共3页 Chinese Journal of Marine Drugs
  • 相关文献

参考文献2

二级参考文献1

  • 1Thomas H. Corbett,Frederick A. Valeriote,Laurence H. Baker. Is the P388 murine tumor no longer adequate as a drug discovery model?[J] 1987,Investigational New Drugs(1):3~20

共引文献13

同被引文献53

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部